Your browser doesn't support javascript.
loading
Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.
Baumann, Pierre; Bauknecht, Philipp; Kuzin, Maxim; Schoretsanitis, Georgios.
Affiliation
  • Baumann P; Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Bauknecht P; Dr. Carl GmbH, Stuttgart, Germany.
  • Kuzin M; Clienia Schloessli, Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich, Oetwil am See/Zurich, Switzerland.
  • Schoretsanitis G; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Int J Psychiatry Clin Pract ; 27(4): 367-384, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37428441
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Type of study: Guideline Limits: Humans Language: En Journal: Int J Psychiatry Clin Pract Year: 2023 Document type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Type of study: Guideline Limits: Humans Language: En Journal: Int J Psychiatry Clin Pract Year: 2023 Document type: Article Affiliation country: Switzerland